share_log

Shareholders in Yunnan Baiyao GroupLtd (SZSE:000538) Are in the Red If They Invested Three Years Ago

Shareholders in Yunnan Baiyao GroupLtd (SZSE:000538) Are in the Red If They Invested Three Years Ago

云南白药集团有限公司(深交所代码:000538)的股东如果在三年前投资,就会陷入亏损
Simply Wall St ·  2023/11/17 17:11

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But in any portfolio, there are likely to be some stocks that fall short of that benchmark. Unfortunately, that's been the case for longer term Yunnan Baiyao Group Co.,Ltd (SZSE:000538) shareholders, since the share price is down 28% in the last three years, falling well short of the market decline of around 11%.

为了证明选择个股的努力是合理的,值得努力击败市场指数基金的回报。但是,在任何投资组合中,都可能有一些股票未达到该基准。不幸的是,从长远来看,云南白药集团有限公司就是这样。, Ltd (SZSE: 000538) 的股东,由于股价在过去三年中下跌了28%,远未达到11%左右的市场跌幅。

So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress.

因此,让我们来看看公司的长期表现是否与基础业务的进展一致。

View our latest analysis for Yunnan Baiyao GroupLtd

查看我们对云南白药集团有限公司的最新分析

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

尽管一些人继续教导高效市场假说,但事实证明,市场是反应过度的动态系统,投资者并不总是理性的。考虑市场对公司的看法发生了怎样的变化的一种不完美但简单的方法是将每股收益(EPS)的变化与股价走势进行比较。

During the three years that the share price fell, Yunnan Baiyao GroupLtd's earnings per share (EPS) dropped by 0.5% each year. The share price decline of 10% is actually steeper than the EPS slippage. So it seems the market was too confident about the business, in the past.

在股价下跌的三年中,云南白药集团有限公司的每股收益(EPS)每年下降0.5%。10%的股价跌幅实际上比每股收益的下滑幅度更大。因此,过去市场似乎对该业务过于自信。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

你可以在下面看到 EPS 是如何随着时间的推移而变化的(点击图片发现确切的值)。

earnings-per-share-growth
SZSE:000538 Earnings Per Share Growth November 17th 2023
深交所:000538 每股收益增长 2023 年 11 月 17 日

We know that Yunnan Baiyao GroupLtd has improved its bottom line lately, but is it going to grow revenue? This free report showing analyst revenue forecasts should help you figure out if the EPS growth can be sustained.

我们知道云南白药集团有限公司最近提高了利润,但它会增加收入吗?这份显示分析师收入预测的免费报告应该可以帮助您弄清楚每股收益的增长是否可以持续。

What About Dividends?

分红呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. As it happens, Yunnan Baiyao GroupLtd's TSR for the last 3 years was -22%, which exceeds the share price return mentioned earlier. The dividends paid by the company have thusly boosted the total shareholder return.

在考虑投资回报时,重要的是要考虑两者之间的区别 股东总回报 (TSR) 和 股价回报。股价回报仅反映股价的变化,而股东总回报率包括股息的价值(假设股息已被再投资)以及任何折扣融资或分拆的收益。可以公平地说,股东总回报率为支付股息的股票提供了更完整的画面。碰巧的是,云南白药集团有限公司过去3年的股东总回报率为-22%,超过了前面提到的股价回报率。因此,该公司支付的股息促进了 股东回报。

A Different Perspective

不同的视角

While the broader market lost about 5.5% in the twelve months, Yunnan Baiyao GroupLtd shareholders did even worse, losing 11% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Longer term investors wouldn't be so upset, since they would have made 1.5%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Yunnan Baiyao GroupLtd has 1 warning sign we think you should be aware of.

尽管大盘在过去十二个月中下跌了约5.5%,但云南白药集团有限公司的股东表现更差,损失了11%(甚至包括股息)。但是,可能仅仅是股价受到了更广泛的市场紧张情绪的影响。如果有很好的机会,可能值得关注基本面。长期投资者不会那么沮丧,因为他们本可以在五年内每年赚1.5%。如果基本面数据继续显示长期可持续增长,那么当前的抛售可能是一个值得考虑的机会。我发现从长远来看,将股价视为业务表现的代表非常有趣。但是,要真正获得见解,我们还需要考虑其他信息。以风险为例,云南白药集团有限公司有 1 个警告信号,我们认为你应该注意。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

如果你想看看另一家公司——一家财务状况可能优异的公司——那么千万不要错过这份已经证明自己可以增加收益的公司的免费名单。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发